ScinoPharm Taiwan, Ltd. (TPE: 1789)
Taiwan
· Delayed Price · Currency is TWD 24.70
+0.05 (0.20%)
Sep 13, 2024, 1:30 PM CST
ScinoPharm Taiwan Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 12, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 19,492 | 20,876 | 20,124 | 19,492 | 22,813 | 21,034 | Upgrade
|
| Market Cap Growth | -4.13% | 3.73% | 3.25% | -14.56% | 8.46% | 10.14% | Upgrade
|
| Enterprise Value | 15,937 | 17,530 | 16,527 | 16,275 | 19,607 | 18,509 | Upgrade
|
| Last Close Price | 24.65 | 26.13 | 24.88 | 23.64 | 27.11 | 24.79 | Upgrade
|
| PE Ratio | 49.31 | 72.57 | 55.69 | 76.79 | 76.00 | 91.83 | Upgrade
|
| PS Ratio | 5.69 | 6.55 | 6.17 | 7.06 | 7.40 | 7.27 | Upgrade
|
| PB Ratio | 1.88 | 2.01 | 1.93 | 1.85 | 2.17 | 2.05 | Upgrade
|
| P/FCF Ratio | 57.34 | -559.62 | 37.93 | 99.75 | 29.77 | 30.64 | Upgrade
|
| P/OCF Ratio | 37.95 | 90.32 | 26.01 | 38.23 | 24.11 | 26.66 | Upgrade
|
| EV/Sales Ratio | 4.65 | 5.50 | 5.06 | 5.89 | 6.36 | 6.40 | Upgrade
|
| EV/EBITDA Ratio | 17.44 | 23.07 | 19.93 | 24.83 | 25.99 | 28.10 | Upgrade
|
| EV/EBIT Ratio | 36.05 | 55.74 | 40.76 | 56.39 | 52.18 | 69.36 | Upgrade
|
| EV/FCF Ratio | 46.89 | -469.93 | 31.15 | 83.29 | 25.58 | 26.96 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.71 | 0.80 | 0.80 | 0.83 | 0.75 | 1.24 | Upgrade
|
| Debt / FCF Ratio | 1.92 | -16.62 | 1.28 | 2.85 | 0.75 | 1.22 | Upgrade
|
| Asset Turnover | 0.29 | 0.27 | 0.28 | 0.23 | 0.26 | 0.24 | Upgrade
|
| Inventory Turnover | 1.27 | 1.46 | 1.59 | 1.14 | 1.49 | 1.38 | Upgrade
|
| Quick Ratio | 4.83 | 6.52 | 6.16 | 8.04 | 6.59 | 5.59 | Upgrade
|
| Current Ratio | 6.86 | 8.75 | 7.87 | 10.73 | 8.62 | 7.29 | Upgrade
|
| Return on Equity (ROE) | 3.92% | 2.76% | 3.37% | 2.31% | 2.71% | 2.08% | Upgrade
|
| Return on Assets (ROA) | 2.31% | 1.66% | 2.15% | 1.53% | 2.00% | 1.38% | Upgrade
|
| Return on Capital (ROIC) | 2.53% | 1.78% | 2.28% | 1.63% | 2.12% | 1.45% | Upgrade
|
| Earnings Yield | 2.03% | 1.38% | 1.76% | 1.25% | 1.24% | 1.03% | Upgrade
|
| FCF Yield | 1.74% | -0.18% | 2.64% | 1.00% | 3.36% | 3.26% | Upgrade
|
| Dividend Yield | 1.24% | 1.15% | 1.45% | 2.03% | 1.84% | 1.09% | Upgrade
|
| Payout Ratio | 70.64% | 99.17% | 107.46% | 162.39% | 75.69% | 178.84% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | 0.04% | -0.05% | -0.01% | -0.01% | 0.13% | Upgrade
|
| Total Shareholder Return | 1.23% | 1.19% | 1.40% | 2.02% | 1.83% | 1.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.